| Buprenorphine-Precipitated Withdrawal Hotspots and Correlates |
CTN-0134 |
Development |
| Exploring Health Beliefs for Community Engagement and Diversity in Clinical Trials |
CTN-0133 |
Development |
| Ketamine for Methamphetamine Use Disorder Study |
CTN-0132 |
Development |
| Methadone or Enhanced Buprenorphine to Address Retention Among Patients not Optimally Benefitting from Office-based Buprenorphine – a Hybrid Effectiveness/Implementation Trial |
CTN-0131 |
Development |
| Quantifying How Cocaine Users Respond to Fentanyl Contamination in Cocaine |
CTN-0130 |
Development |
| The Great Plains Initiative |
CTN-0129 |
Development |
| Adherence and Feasibility of Wearable Technologies and Ecological Momentary Assessment to Assess Autonomic Function and Negative Affect in Opioid Use Disorder. |
CTN-0128 |
Development |
| Engaging African American Faith-based leaders in a Substance Use Learning Collaborative |
CTN-0127 |
Development |
| Longitudinal Follow-up of Individuals with Opioid Use Disorder |
CTN-0126 |
Development |
| Using Integrative Data Analysis to Examine the Impact of Psychosocial Treatments for Black Cocaine Users Enrolled in the CTN |
CTN-0125 |
Development |
| Assessment and Design of a Cost-Effective Collaborative MOUD Delivery System |
CTN-0124 |
Development |
| Facebook intervention for preventing opioid relapse among American Indian Women |
CTN-0123 |
Development |
| Comprehensive Meta-Analysis of CTN Treatment Outcomes by Race and Sex |
CTN-0122 |
Development |
| Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders (SUD) among Hospitalized Patients |
CTN-0121 |
Development |
| R-Mist: Remote Methadone Ingestion Surveillance Trial |
CTN-0120 |
Development |
| Impact of Social Distancing Measures, Expansion of Telemedicine for Buprenorphine Prescribing, and Health Insurance Payor on Access to Buprenorphine During the COVID-19 Pandemic |
CTN-0119 |
Active |
| Examining the COVID-19 Public Health Emergency on Policy, Substance Use Disorder, Treatment and Resilience among American Indian and Alaska Native Communities |
CTN-0118 |
Development |
| The Impact of COVID-19 Pandemic on Substance Use Treatment Services |
CTN-0117 |
Development |
| Pharmacist-Integrated Model of Medication Treatment for Opioid Use Disorder |
CTN-0116 |
Development |
| Developing an Intervention to Address Intersecting Prescription Opioid and Chronic Pain Stigma in Cancer Survivors (NIH HEAL Initiative) |
CTN-0115 |
Active |
| Drug Repurposing for Cocaine Use Disorder (CUD) Using a Combined Strategy of Artificial Intelligence (AI)-Based Prediction and Retrospective Clinical Corroboration |
CTN-0114 |
Active |
| Validating a DSM-5 Substance Use Disorder (SUD) Symptom Checklist in EHR Data from a Large Primary Care Sample to Support Future Pragmatic Trials and Chronic Care Management of SUDs in Primary Care |
CTN-0113 |
Active |
| Optimal Policies to Improve Methadone Maintenance Adherence Long-Term (OPTIMMAL) |
CTN-0112 |
Development |
| COVID-19 and Substance Misuse Case Identification using Data Science: A Retrospective Cohort Study |
CTN-0111 |
Active |
| Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine for Methamphetamine Use Disorder (MURB) |
CTN-0110 |
Development |
| Innovative Development of Research Engagement Manual (I-DREM): Strategies to Enhance Recruitment and Retention of Black Individuals in CTN-0109 CURB-2 |
CTN-0109-A-1 |
Development |
| Randomized, Placebo-Controlled Trial of Injectable Naltrexone and Monthly Injectable Buprenorphine for Cocaine Use Disorder (CURB-2) |
CTN-0109 |
Development |
| Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder |
CTN-0108 |
Development |
| Peer Intervention to Link Overdose survivors to Treatment (PILOT) (NIH HEAL Initiative) |
CTN-0107 |
Development |
| Derivation and Validation of New Measurement-Based Care Tools Derived from the Brief Addiction Monitor (NIH HEAL Initiative) |
CTN-0106 |
Completed |
| Integrating pharmacy-based prevention and treatment of opioid and other substance use disorders: A survey of pharmacists and stakeholder (NIH HEAL Initiative) |
CTN-0105 |
Development |
| Healthcare Provider Stigma Related to the Opioid Use Epidemic and its Impact on Patient Treatment and Clinical Management |
CTN-0104 |
Active |
| Expanding Clinical Research Training on Implementing the Evidence-based Hub and Spoke Model of Medication-Assisted Treatment for Opioid Use Disorder (NIH HEAL Initiative) |
CTN-0103 |
Completed |
| COVID Impact on Rural Expansion of Medication Treatment for Opioid Use Disorder |
CTN-0102-A-1 |
Active |
| Rural Expansion of Medication Treatment for Opioid Use Disorder (NIH HEAL Initiative) |
CTN-0102 |
Active |
| Subthreshold Opioid Use Disorder Prevention (STOP) Trial (NIH HEAL Initiative) |
CTN-0101 |
Active |
| Optimizing Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (NIH HEAL Initiative) |
CTN-0100 |
Active |
| Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION) (NIH HEAL Initiative) |
CTN-0099 |
Active |
| Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE) (NIH HEAL Initiative) |
CTN-0098 |
Active |
| Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder (NIH HEAL Initiative) |
CTN-0097 |
Active |
| National Medication-Assisted Treatment Survey of Substance Use Disorder Programs Serving American Indian and Alaska Native People (NIH HEAL Initiative) |
CTN-0096-A-1 |
Active |
| Culturally Centered MAT for OUD Implementation Facilitation for Primary Care and Addiction Treatment Programs Serving American Indian/Alaska Natives (NIH HEAL Initiative) |
CTN-0096 |
Active |
| Reducing Stigma Toward People with Opioid Use Disorder Among Primary Care Clinicians (NIH HEAL Initiative) |
CTN-0095-A-2 |
Active |
| Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder (NIH HEAL Initiative) |
CTN-0095-A-1 |
Active |
| Clinic-Randomized Trial of Clinical Decision Support for Opioid Use Disorders in Medical Settings (NIH HEAL Initiative) |
CTN-0095 |
Active |
| Individual Level Predictive Modeling of Opioid Use Disorder Treatment Outcome (NIH HEAL Initiative) |
CTN-0094 |
Active |
| Validation of a Community Pharmacy-based Prescription Drug Monitoring Program Risk Screening Tool (PHARMSCREEN) (NIH HEAL Initiative) |
CTN-0093 |
Completed |
| Preventing and Identifying Opioid Use Disorder using the Six Building Blocks (6BBs) for Improving Opioid Prescription Management (NIH HEAL Initiative) |
CTN-0091 |
Completed |
| Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution (NIH HEAL Initiative) |
CTN-0090 |
Completed |
| Integrating Nurse Practitioner Buprenorphine Waiver Training into Graduate Nursing Curriculum (NIH HEAL Initiative) |
CTN-0089 |
Completed |
| DC Research Infrastructure Building & Initiative to Reach, Engage, and Retain in MAT patients with OUD (NIH HEAL Initiative) |
CTN-0088 |
Active |
| A Foundation to Examine Reasons for Discontinuation for Buprenorphine Care in the Veterans Health Administration (NIH HEAL Initiative) |
CTN-0087 |
Completed |
| Inpatient versus Outpatient Treatment Outcomes for People with Opioid Use Disorder (NIH HEAL Initiative) |
CTN-0086 |
Completed |
| Selection Bias-Free Estimation of the Impact of Drug-Focused 12-step Mutual Help Groups (NIH HEAL Initiative) |
CTN-0085 |
Completed |
| Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder (D-TECT) (NIH HEAL Initiative) |
CTN-0084-A-2 |
Active |
| Determining the Optimal Duration of Buprenorphine Treatment to Reduce the Risk of Relapse, Overdose, and Mortality (NIH HEAL Initiative) |
CTN-0084-A-1 |
Completed |
| Developing a Prescription Opioid Registry across Diverse Health Systems (NIH HEAL Initiative) |
CTN-0084 |
Completed |
| Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP Services |
CTN-0083 |
Completed |
| Vaccine Readiness in People Who Use Substances In Community STI Clinics and Substance Use Intervention or Harm Reduction Programs In Eight Higher HIV Incidence Southeastern Cities |
CTN-0082-A-1 |
Completed |
| Implementation Survey of PrEP and Opioid Use Related Services in STI Clinics and MSM-Centered Community Based Organizations (CBOs) |
CTN-0082 |
Completed |
| Emergency Medicine Opioid Data Infrastructure: Key Venue to Address Opioid Morbidity and Mortality (Project CODE PRO – Capturing Opioid Use Disorder Electronically and Patient Reported Outcomes) |
CTN-0081 |
Completed |
| Medication Treatment for Opioid-dependent Expecting Mothers (MOMs): A Pragmatic Randomized Trial Comparing Two Buprenorphine Formulations (NIH HEAL Initiative) |
CTN-0080 |
Active |
| Ancillary Study of the Adoption and Sustainability of ED-Initiated Buprenorphine (NIH Heal Initiative) |
CTN-0079-A-1 |
Active |
| Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT) |
CTN-0079 |
Completed |
| Knowledge of and Attitudes about Medication Assisted Treatment within American Indian Communities |
CTN-0078 |
Completed |
| Medical Cannabis Use among Primary Care Patients: Using Electronic Health Records to Study Large Populations |
CTN-0077 |
Completed |
| Clinical decision support for Opioid use disorders in Medical settings: Pilot Usability Testing in an EMR (COMPUTE) |
CTN-0076 |
Completed |
| Pharmacy Screening and Collaborative Opioid Use Disorder Care (Pharm-OUD-Care) |
CTN-0075 |
Completed |
| Primary Care Opioid Use Disorders Treatment Trial Economic Analysis Study (NIH HEAL Initiative) |
CTN-0074-A-1 |
Completed |
| Primary Care Opioid Use Disorders Treatment Trial |
CTN-0074 |
Completed |
| Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network |
CTN-0073 |
Completed |
| Patient and System-Level Factors Associated with HEDIS AOD-IET Measure Performance across Health Systems |
CTN-0072 |
Completed |
| Electronic Health Records Data Elements Research (EHR-DARE) |
CTN-0071 |
Completed |
| Interpretation and Implementation of Title 42 CFR Part 2 for Confidentiality of Patient Drug and Alcohol Use Records: NIDA CTN Stakeholder Snapshot |
CTN-0070 |
Completed |
| Opioid Use Disorder in the Emergency Department |
CTN-0069 |
Completed |
| Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder |
CTN-0068 |
Completed |
| Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES); Scale-Up |
CTN-0067 |
Completed |
| Opioid Use Disorders in Primary Care Settings: Linking EHRs with PDMP and National Death Index Data Systems |
CTN-0066 |
Completed |
| Evaluation of Drug Screening Implementation in Primary Care |
CTN-0065 |
Completed |
| Linkage to Hepatitis C Virus Care among HIV/HCV Co-infected Substance Users |
CTN-0064 |
Completed |
| Gender Differences in the Interrelationships between Sexual Abuse, Risky Sexual Behavior, and Anxiety/Depression in Treatment Efficacy and Drug Use over Time among Individuals with Substance Use Disorders |
CTN-0063 |
Completed |
| A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements into the Electronic Health Record in Large Primary Care Settings |
CTN-0062 |
Completed |
